Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 80Stomach Neoplasms 66Rectal Neoplasms 39Pancreatic Neoplasms 31Colonic Neoplasms 27Esophageal Neoplasms 24Lymphoma, Large B-Cell, Diffuse 20Neoplasms 19Adenocarcinoma 19Cholangiocarcinoma 16Neoplasm Metastasis 15Adenocarcinoma Of Esophagus 14Biliary Tract Neoplasms 12Carcinoma, Non-Small-Cell Lung 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Ovarian Neoplasms 10Gastrointestinal Neoplasms 7Gallbladder Neoplasms 7Carcinoma, Hepatocellular 7Locally Advanced Rectal Cancer 6Esophageal Squamous Cell Carcinoma 6Endometrial Neoplasms 6Recurrence 4Lymphoma 4Carcinoma 4Bile Duct Neoplasms 4Advanced Solid Tumors 4Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Peritoneal Neoplasms 3

Interventions

tislelizumab 1Taxes 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Fluorouracil 1Etoposide 1Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced and Metastatic Solid Tumors × Oxaliplatin × 1 year × Clear all
NCT04047862 2025-08-22

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

BeiGene

Phase 1 Completed
446 enrolled 49 charts
Other solid neoplasm

Locally Advanced and Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡